Vimarsana
Biggest News Aggregation in the World

Page 2 - Project Twenty News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Project Twenty. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Project Twenty Today - Breaking & Trending Today

Leva Clinic Raises $3.5M in Funding - Vimarsana News

Leva Clinic Raises $3.5M in Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Leva Clinic, chronic pain and medical cannabis leaders, raise $3.5m to transform treatment for UK pain patients - Vimarsana News

Leva Clinic, chronic pain and medical cannabis leaders, raise $3.5m to transform treatment for UK pain patients

London, UK (PRWEB) November 07, 2022 -- - Leva Clinic (“Leva”) operates the UK’s first online clinic for chronic pain, owns one of the UK’s leading brands of

Source: prweb.com
Leva Clinic fundraises £3m for UK's first digital chronic pain platform - Vimarsana News

Leva Clinic fundraises £3m for UK's first digital chronic pain platform

Funding will be used to broaden partnerships with the NHS and improve patient experience - News - PharmaTimes

Khiron Life Sciences Corp. (KHRNF) Q2 2022 Earnings Call Transcript - Vimarsana News

Khiron Life Sciences Corp. (KHRNF) Q2 2022 Earnings Call Transcript

Khiron Life Sciences Corp. (OTCQX:KHRNF) Q2 2022 Earnings Conference Call August 29, 2022 10:00 AM ET Company Participants Paola Ricardo - Investor Relations Alvaro Torres - CEO and...

Akanda's CanMart Partners with Phlo Connect and Cellen Life Sciences to Dispense & Deliver High Quality Medical Cannabis Products in the UK - Vimarsana News

Akanda's CanMart Partners with Phlo Connect and Cellen Life Sciences to Dispense & Deliver High Quality Medical Cannabis Products in the UK

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com